BUPREXONE
Live / Registered — Registered — Section 8 accepted (as of 12 Jan 2026)
What this means for you
Registered since 06 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87917143
- Registration number
- 5829816
- Mark type
- Stylized text
- Filed
- 11 May 2018
- Published for opposition
- 23 Oct 2018
- Registered
- 06 Aug 2019
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of opiate addiction
Owner
- Matthew 7:25 Inc., Jacksonville, FL, US
- Matthew 7:25 Inc., Jacksonville, FL, US
- Matthew 7:25 Inc., Jacksonville, FL, US
Prosecution history
- 12 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 12 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 12 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Sept 2025 — TEAS SECTION 8 RECEIVED
- 06 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 29 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jun 2019 — USE AMENDMENT FILED
- 21 Jun 2019 — SOU EXTENSION 1 GRANTED
- 18 Jun 2019 — SOU EXTENSION 1 FILED
- 21 Jun 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jun 2019 — SOU TEAS EXTENSION RECEIVED